Where does Tulex Pharmaceuticals Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tulex Pharmaceuticals Inc. ranks #38,053 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tulex Pharmaceuticals Inc. hold?

Tulex Pharmaceuticals Inc. holds 7 US utility patents granted between 2022 and 2025, spanning 4 technology areas.

What is Tulex Pharmaceuticals Inc.'s Innovation Score?

Tulex Pharmaceuticals Inc. has an Innovation Score of 46.8 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tulex Pharmaceuticals Inc. focus on?

Tulex Pharmaceuticals Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents, ranking #3,032 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Tulex Pharmaceuticals Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Tulex Pharmaceuticals Inc..

What does claim depth mean for Tulex Pharmaceuticals Inc.'s patents?

Tulex Pharmaceuticals Inc.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tulex Pharmaceuticals Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tulex Pharmaceuticals Inc.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tulex ranks #38,053 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#38,053
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.8/100): 20.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R38053 · US Corporation #38,053 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
LOWER-Q #38,053/49,997
PHOTO-FINISH Truva
CPC-NARROW A61K · 4 areas
INNOV-PAR 46.8/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Truva Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tulex’s 46.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (15%) Velocity 20.0 pts (43%) Breadth 7.1 pts (15%) Claim depth 12.5 pts (27%)

Qualcomm Incorporated · highest

85
Spectra Systems · near

47
Umbra · near

47
Claremont Biosolutions · near

47
Enlitic · near

47
Tulex Pharmaceuticals · this assignee

47
3D Lighting… · lowest

7

What this shows Tulex's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tulex?

Each dot is one of Tulex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tulex’s own 20.9 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tulex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tulex's grants concentrate

Tulex Pharmaceuticals Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2022. By volume, Tulex sits between Truva Corporation and Tweedy's Speed Protectors, LLC.

Tulex's three-year grant acceleration

Tulex Pharmaceuticals Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Truva

7
Tryten

7
Tsurumi Manufactu…

7
Tubel

7
Tuper S/A

7
Turning Point Dis…

7
Tutela

7
Tweedy's Speed Pr…

7
Tulex Pharmaceuti… ◀

7

What this shows Tulex holds 7 patents at rank #38,029, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tulex

By rank, the assignees closest to #38,029 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Tulex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tulex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Tulex ranks #3,032 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Claremont Biosolutions LLC 47 Enlitic, Inc. 47 Spectra Systems Corporation 47 Umbra Technologies Ltd. 47

Tulex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Tulex Pharmaceuticals Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	14.3%
2023	2	28.6%
2024	1	14.3%
2025partial year	3	42.9%

Which technologies does Tulex Pharmaceuticals Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 5

C07K - Peptides 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tulex Pharmaceuticals Inc.'s patent record in context - here's where to go next.

Tulex Pharmaceuticals Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #38,053 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tulex Pharmaceuticals Inc. against Truva Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.